Cmax for enteric coated product [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2014-04-13 11:21 (4456 d 21:26 ago) – Posting: # 12828
Views: 2,411

Hi Ken Peh,

❝ For enteric coated tablets, there is a lag time in the absorption. The lag time varies a lot in the same subject for two different treatment and also between subjects. For this type of product, it it a must to follow the 90%CI limit of 0.80 -1.25 ?


Yes, either that, or perhaps you can do scaling in a study with replication of the ref and observed CV>30%. If you opt for a 2-stage design then you might be dealing with an e.g. 94.12% CI rather than 90% CI etc.
You may have some options here but I think Cmax must show BE one way or another almost regardless of where you intend to submit.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
167 visitors (1 registered, 166 guests [including 34 identified bots]).
Forum time: 08:48 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5